Q4 2024 · 13F-HR
STEMPOINT CAPITAL LPholdings as filed
Filed 2025-02-14 · accession 0001420506-25-000514
$400.6M
Reported value
54
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $38.0M | 9.48% | 2,872,601 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $32.1M | 8.01% | 2,712,778 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $27.7M | 6.92% | 1,118,508 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $25.9M | 6.45% | 614,812 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $16.2M | 4.05% | 317,060 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $14.7M | 3.68% | 375,845 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $13.4M | 3.34% | 193,623 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $12.0M | 2.99% | 416,968 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $11.9M | 2.97% | 584,328 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $11.6M | 2.91% | 208,016 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $11.4M | 2.84% | 145,234 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $10.8M | 2.68% | 641,964 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $10.3M | 2.58% | 134,178 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $9.4M | 2.34% | 166,068 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $8.9M | 2.23% | 721,209 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $8.5M | 2.11% | 193,535 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $8.4M | 2.10% | 992,803 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $7.8M | 1.95% | 145,876 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $7.4M | 1.84% | 106,610 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $7.2M | 1.79% | 166,307 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $7.0M | 1.75% | 949,401 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $7.0M | 1.75% | 61,403 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $7.0M | 1.74% | 500,966 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $7.0M | 1.74% | 186,413 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $5.9M | 1.48% | 2,328,492 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.5M | 1.37% | 141,714 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $5.4M | 1.34% | 1,704,825 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $5.0M | 1.26% | 350,573 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.9M | 1.23% | 400,101 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $4.5M | 1.13% | 428,137 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $4.3M | 1.08% | 579,500 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.3M | 1.07% | 101,809 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $4.3M | 1.07% | 545,800 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $3.9M | 0.98% | 83,576 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $3.9M | 0.97% | 265,833 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $3.5M | 0.88% | 132,706 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $3.4M | 0.85% | 270,983 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $2.9M | 0.72% | 135,244 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $2.6M | 0.64% | 126,400 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $2.2M | 0.54% | 96,716 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.1M | 0.53% | 200,900 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $1.8M | 0.44% | 332,394 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.6M | 0.40% | 90,000 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $1.5M | 0.38% | 150,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $1.3M | 0.33% | 28,136 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $1.3M | 0.32% | 47,642 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $725,720 | 0.18% | 200,475 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $580,625 | 0.14% | 1,575,000 | CALL | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $514,500 | 0.13% | 70,000 | PUT | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $435,568 | 0.11% | 9,434 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $413,775 | 0.10% | 85,000 | PUT | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $227,500 | 0.06% | 100,000 | CALL | SOLE |
| 433000106 | HIMS | HIMS & HERS HEALTH INC | $75,000 | 0.02% | 75,000 | CALL | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $51,025 | 0.01% | 234,100 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.